PF
GILD icon

Phoenix Financial’s Gilead Sciences GILD Stock Holding History

Phoenix Financial’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.07M Buy
24,316
+4,037
+20% +$532K 0.02% 161
2026
Q1 		$2.83M Buy
20,279
+8,155
+67% +$1.14M 0.03% 150
2025
Q4 		$1.49M Buy
12,124
+963
+9% +$117K 0.02% 203
2025
Q3 		$1.24M Buy
11,161
+1,067
+11% +$121K 0.02% 212
2025
Q2 		$1.12M Buy
10,094
+564
+6% +$60K 0.01% 225
2025
Q1 		$1.07M Buy
9,530
+5,585
+142% +$576K 0.02% 209
2024
Q4 		$364K Sell
3,945
-13,079
-77% -$1.18M 0.01% 292
2024
Q3 		$1.43M Buy
+17,024
New +$1.3M 0.02% 203
2020
Q4 		– Sell
-31,114
Closed -$1.82M – 388
2020
Q3 		$1.82M Buy
31,114
+3,098
+11% +$215K 0.08% 164
2020
Q2 		$1.99M Sell
28,016
-13,675
-33% -$1.05M 0.08% 160
2020
Q1 		$3.03M Sell
41,691
-138,162
-77% -$9.55M 0.15% 128
2019
Q4 		$11.6M Sell
179,853
-70,547
-28% -$4.59M 0.49% 77
2019
Q3 		$15.1M Buy
+250,400
New +$16.4M 0.72% 63

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Phoenix Financial's GILD Position: Q2 2026 in Review

Phoenix Financial increased its Gilead Sciences (GILD) stake by 20% in Q2 2026, buying an estimated $532K and bringing the position to 24,316 shares worth $3.07M. The position accounts for 0.02% of the portfolio, ranked #161.

Phoenix Financial first reported a position in GILD in Q3 2019 and has held it in 13 quarters since. The position peaked at $15.1M in Q3 2019. 2,291 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Phoenix Financial held 24,316 shares of Gilead Sciences worth $3.07M as of Q2 2026.
  • Phoenix Financial bought 4,037 Gilead Sciences shares in Q2 2026, an estimated $532K.
  • Gilead Sciences made up 0.02% of Phoenix Financial's portfolio in Q2 2026, its #161 holding.
  • Phoenix Financial first reported a position in Gilead Sciences in Q3 2019 and has held it in 13 quarters since.
  • Phoenix Financial's Gilead Sciences position peaked at $15.1M in Q3 2019.
  • 2,291 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Phoenix Financial's 13F filing for Q2 2026, filed 11 Aug 2026.